Addex Therapeutics Ltd - Company Profile
Powered by 
All the sales intelligence you need on Addex Therapeutics Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Addex Therapeutics Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Addex Therapeutics Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Addex Therapeutics Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Addex Therapeutics Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Vincent Lawton
Chairman Executive BoardMr. Vincent Lawton has been the Chairman of the company since 2009. Prior to this, he served as the Managing Director of Merck Sharp & Dohme (MSD) U.K. and the Vice President of MSD Europe, subsidiaries of Merck & Co Inc, until 2006. Previously, he served as the President of the Association of the British Pharmaceutical Industry. Mr. Lawton also served as a founding member of the U.K. Clinical Research Collaboration, the Ministerial Industry Strategy Group, the Pharmaceutical Industry Competitiveness Task Force.
Tim Dyer
Chief Executive Officer; Director Executive BoardMr. Tim Dyer has been the Chief Executive Officer and Director of the company since 2013. Prior to this, he served as the Chief Financial Officer of the company. Mr. Dyer is Co-founder of Addex and had joined the group in 2002. Prior to joining Addex, Mr. Dyer served Price Waterhouse (PW) & PricewaterhouseCoopers (PwC) in the UK and Switzerland. He is also a member of the board of directors of of Abionic SA and Qwane Biosciences SA.
Roger G. Mills, M.D.
Chief Medical Officer; Director Executive BoardDr. Roger G. Mills has been the Chief Medical Officer and Director of the company since 2017. Prior to this, he served as the Executive Vice President, Development and the Chief Medical Officer at Acadia Pharmaceuticals. Currently, he also serves as a Visiting Professor at the Center for Age-Related Diseases, Institute of Psychiatry, Psychology and Neuroscience, King’s College London.
Mikhail Kalinichev, PhD
Head - Translational Science Senior ManagementLenaic Teyssedou
Head - Finance Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer